Fluticasone Propionate
Brand names: Flixotide, Flixonase (nasal)
Fluticasone propionate is an inhaled corticosteroid used in children for the maintenance prophylaxis of asthma; this page covers the inhaled preventer rather than systemic or nasal preparations.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
A potent glucocorticoid that, after delivery to the airways, binds glucocorticoid receptors to suppress airway inflammation, reduce mucosal oedema and decrease bronchial hyper-responsiveness.
Prescribing in practice
- Inhaled corticosteroids can cause growth retardation in children, so use the lowest effective dose, monitor height and review the need for treatment regularly.
- Use an age-appropriate spacer (with facemask in young children) and correct inhaler technique to maximise lung deposition and reduce oropharyngeal effects.
- It is a preventer, not a reliever, and must be taken regularly even when the child is well.
Monitoring
Monitor the child's height and growth, asthma control and inhaler technique at routine reviews.
Counselling the patient
- Rinse the mouth and spit out after each dose to reduce the risk of oral thrush and hoarseness.
- Use every day as a preventer, not for sudden breathlessness.
- Always use the prescribed spacer device and bring it to reviews so technique can be checked.
Evidence & guidelines
Inhaled corticosteroids are first-line preventer therapy in paediatric asthma per NICE/BTS-SIGN guidance.
Reference: BTS/SIGN Asthma Guidelines 2019; MHRA Drug Safety Update 2018 (fluticasone/ritonavir); NICE NG80; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.